Pipeline

Nature gave us glial cells. We unlock their potential. GliaPharm’s pioneering approach is to stimulate energy utilization in the brain by targeting a type of glial cells called astrocytes.

While the importance of glial cells has been largely overlooked in neuro drug development, it is now clear that these cells play a key role in sustaining brain functions and neuroprotection.

Lead
Compound

Indications
Compounds
Screening
Lead 

optimization
In vivo efficacy
/ Pre-IND
IND-

enabling
Phase I
Phase Ib -

Biomakers
Phase 2
Alzheimer’s
Disease
GP-119
0%
GLUT1-DS
(Orphan Disease)
GP-119
0%
ALS
(Orphan Disease)
GP-119
0%

Additional
chemical series

Indications
Compounds
Screening
Lead 

optimization
In vivo efficacy
/ Pre-IND
IND-

enabling
Phase I
Phase Ib -

Biomakers
Phase 2

Indications
with Brain
Hypo
metabolism
Series
GP-61
0%
Series
GP-62
0%